The endocannabinoids, 2-arachidonoyl glycerol (2-AG) and arachidonoyl ethanolamide (AEA), are biologically active lipids that regulate diverse neurological and metabolic functions by activating the cannabinoid receptors, central cannabinoid (CB1) and peripheral cannabinoid (CB2). Monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH) hydrolyze 2-AG and AEA, respectively, thus terminating their biological function. IDFP is an organophosphorus compound that dually inhibits MAGL and FAAH with IC50 values of 0.8 and 3 nM, respectively.1 At 10 mg/kg, IDFP elevates brain levels of 2-AG and AEA more than 10-fold, and decreases levels of arachidonic acid by a similar magnitude.1
1
Nomura, D.K., Blankman, J.L., Simon, G.M., et al. Activation of the endocannabinoid system by organophosphorus nerve agents. Nat Chem Biol4(6)373-378(2008).
Room temperature
in continental US; may vary elsewhere
SMILES
Copy SMILES to clipboard
CCCCCCCCCCCCP(=O)(F)OC(C)C
Background Reading
Nomura, D.K., Blankman, J.L., Simon, G.M., et al. Activation of the endocannabinoid system by organophosphorus nerve agents. Nat Chem Biol4(6)373-378(2008).
IDFP is available in the following screening
library: